FOCUS ON THYMIC TUMOURS
Friday 12 December
| Session 1 | Classification of Thymic Tumours Moderators: M Lucchi, Pisa; S Suster, Wisconsin | |
| 11.00 | Thymoma and thymic carcinoma: an update of the WHO Classification | A Marx, Heidelberg |
| 11.30 | Problem areas and inconsistencies in the WHO classication of thymoma | S Suster, Wisconsin |
| 12.00 | Strategies and novel medical treatments in the therapy of thymomas and thymic carcinomas | P Stroebel, Heidelberg |
| 12.30 | LUNCH | |
| Session 2 | Clinical Aspects of Thymic Tumours Moderators: R Schmid, Bern; C Wright, Boston | |
| 14.00 | Immunological disorders in patients with thymoma | R Mantegazza, Milan |
| 14.30 | Thymoma as incidental finding - preoperative diagnosis | R Mercelis, Antwerp |
| 15.00 | Anaesthesia in patients with myasthenia | P Ten Broecke, Antwerp |
| 15.30 | COFFEE BREAK | |
| 16.00 | Pathological cases. Interactive discussion | E Van Marck, Antwerp; A Marx, Heidelberg; P Stroebel, Heidelberg; S Suster, Wisconsin |
Saturday 13 December
| Session 3 | Surgery for Thymic Tumours Moderators: J Sonett, New York; F Melfi, Pisa | |
| 09.00 | Mini- or maxi-invasive thymectomy: is it a tailoring issue? | J Sonett, New York |
| 09.20 | Maximal thymectomy by VATS approach | M Zielinski, Zakopane |
| 09.40 | Robotic thymectomy: indications and technique | P Van Schil, Antwerp; J Hendriks, Antwerp |
| 10.00 | Robotic thymectomy: results for thymoma | J Ruckert, Berlin |
| 10.20 | COFFEE BREAK | |
| Session 4 | Extended Surgery and recurrence patterns Moderators: F C Detterbeck, Yale; F Venuta, Rome | |
| 11.00 | The objectives and timing of multimodality treatment of advanced stage thymic tumours | E Rendina, Roma |
| 11.20 | Extended resectoin for "unresectable" thymic tumours | W Klepetko, Vienna |
| 11.40 | Predictors of recurrence in thymic tumours | F C Detterbeck, Yale |
| 12.00 | LUNCH | |
| Session 5 | Role of Radio- and Chemotherapy Moderators: R Schmid, Bern; T Treasure, London | |
| 13.00 | Adjuvant radiotherapy: when is it really necessary? | C Goor, Antwerp |
| 13.20 | Chemotherapy for thymic tumours: new drugs or new combinations? | P Loehrer, Indiana |
| 13.40 | A bank of thymic tumours: an international cooperation to overcome the obstacles of studies on a rare disease | J Van Meerbeeck, Ghent |
| 14.00 | Clinical cases - interactive discussion | M Lucchi, Pisa; C Wright, Boston; P Van Schil, Antwerp |
| 15:00 | CLOSE | |
PROGRAMME SUBJECT TO CHANGE